$CTRE
CareTrust REIT Inc Stock $ctre

$ctre Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000162828021001797 Filed on February 10, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2019 Q3
Revenue	$44.14M	$44.23M	$33.31M
YoY Change	-0.21%	9.58%	-15.68%
Cost Of Revenue			$806.0K
YoY Change			5.22%
Gross Profit			$32.51M
YoY Change			-16.1%
Gross Profit Margin			97.58%
Selling, General & Admin	$4.040M	$4.480M	$4.530M
YoY Change	-9.82%	-23.68%	-25.49%
% of Gross Profit			13.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.30M	$13.10M	$13.40M
YoY Change	1.53%	12.93%	18.58%
% of Gross Profit			41.22%
Operating Expenses	$17.52M	$18.21M	$43.59M
YoY Change	-3.79%	0.39%	74.34%
Operating Profit			-$11.08M
YoY Change			-180.6%
Interest Expense	-$5.580M	-$6.920M	$7.064M
YoY Change	-19.36%	3.59%	3.81%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$21.06M	$20.66M	-$10.05M
YoY Change	1.94%	32.95%	-169.26%
Income Tax
% Of Pretax Income
Net Earnings	$21.06M	$20.66M	-$10.05M
YoY Change	1.9%	32.97%	-169.29%
Net Earnings / Revenue	47.7%	46.72%	-30.18%
Basic Earnings Per Share	$0.22	$0.22	-$0.11
Diluted Earnings Per Share	$0.22	$0.22	-$0.11
COMMON SHARES
Basic Shares Outstanding	95.22M shares	95.10M shares	95.10M shares
Diluted Shares Outstanding	95.24M shares	95.14M shares	95.10M shares

Balance Sheet

Concept	2020 Q4	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.90M	$20.30M	$5.700M
YoY Change	-6.9%	-44.84%	-63.69%
Cash & Equivalents	$18.92M	$20.33M	$5.749M
Short-Term Investments
Other Short-Term Assets	$10.50M	$10.90M	$30.20M
YoY Change	-3.67%	25.29%	694.74%
Inventory
Prepaid Expenses
Receivables	$1.800M	$2.600M	$2.100M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$31.20M	$33.80M	$38.00M
YoY Change	-7.69%	-40.6%	19.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.463B	$1.448B	$1.449B
YoY Change	1.08%	17.27%	19.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$3.800M	$3.100M
YoY Change	-100.0%	-33.33%	-45.61%
Other Assets	$9.300M	$37.60M	$37.90M
YoY Change	-75.27%	6166.67%	4111.11%
Total Long-Term Assets	$1.472B	$1.485B	$1.487B
YoY Change	-0.86%	20.26%	23.03%
TOTAL ASSETS
Total Short-Term Assets	$31.20M	$33.80M	$38.00M
Total Long-Term Assets	$1.472B	$1.485B	$1.487B
Total Assets	$1.504B	$1.519B	$1.525B
YoY Change	-1.01%	17.58%	22.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.60M	$15.00M	$16.30M
YoY Change	30.67%	-6.25%	-11.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$43.90M	$36.70M	$37.90M
YoY Change	19.62%	8.58%	6.16%
LONG-TERM LIABILITIES
Long-Term Debt	$545.6M	$554.6M	$559.4M
YoY Change	-1.62%	13.23%	15.44%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$545.6M	$554.6M	$559.4M
YoY Change	-1.62%	13.23%	15.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.90M	$36.70M	$37.90M
Total Long-Term Liabilities	$545.6M	$554.6M	$559.4M
Total Liabilities	$589.4M	$591.3M	$597.3M
YoY Change	-0.31%	12.94%	14.79%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.165B	$1.164B	$1.163B
YoY Change	0.12%	20.44%	26.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$914.1M	$927.6M	$927.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.504B	$1.519B	$1.525B
YoY Change	-1.01%	17.58%	22.93%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	$21.06M	$20.66M	-$10.05M
YoY Change	1.9%	32.97%	-169.29%
Depreciation, Depletion And Amortization	$13.30M	$13.10M	$13.40M
YoY Change	1.53%	12.93%	18.58%
Cash From Operating Activities	$37.30M	$31.10M	$33.50M
YoY Change	19.94%	15.19%	10.56%
INVESTING ACTIVITIES
Capital Expenditures	-$49.50M	-$25.00M	-$14.10M
YoY Change	98.0%	-34.9%	-58.28%
Acquisitions
YoY Change
Other Investing Activities	-$14.00M	$34.90M	-$14.60M
YoY Change	-140.11%	-842.55%	-1722.22%
Cash From Investing Activities	-$63.70M	$10.00M	-$28.80M
YoY Change	-737.0%	-123.2%	-12.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	26.10M	-26.60M	-1.500M
YoY Change	-198.12%	-171.51%	-122.06%
NET CHANGE
Cash From Operating Activities	37.30M	31.10M	33.50M
Cash From Investing Activities	-63.70M	10.00M	-28.80M
Cash From Financing Activities	26.10M	-26.60M	-1.500M
Net Change In Cash	-300.0K	14.50M	3.200M
YoY Change	-102.07%	-31.28%	-23.81%
FREE CASH FLOW
Cash From Operating Activities	$37.30M	$31.10M	$33.50M
Capital Expenditures	-$49.50M	-$25.00M	-$14.10M
Free Cash Flow	$86.80M	$56.10M	$47.60M
YoY Change	54.72%	-14.22%	-25.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001590717
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2018	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	us-gaap:HealthCareResidentServiceMember
CY2020	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	us-gaap:HealthCareResidentServiceMember
CY2019	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	us-gaap:HealthCareResidentServiceMember
CY2019	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:HealthCareResidentServiceMember
CY2018	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:HealthCareResidentServiceMember
CY2020	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:HealthCareResidentServiceMember
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-36181
CY2020	dei	Entity Registrant Name EntityRegistrantName	CareTrust REIT, Inc.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3999490
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	905 Calle Amanecer
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92673
CY2020	dei	City Area Code CityAreaCode	949
CY2020	dei	Local Phone Number LocalPhoneNumber	542-3130
CY2020	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2020	dei	Trading Symbol TradingSymbol	CTRE
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	1600000000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	95893541	shares
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1448099000	USD
CY2019Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1414200000	USD
CY2020Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	15000000	USD
CY2019Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	33300000	USD
CY2020Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	7226000	USD
CY2019Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	34590000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18919000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20327000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1823000	USD
CY2019Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2571000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	10450000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	10850000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2042000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3023000	USD
CY2020Q4	us-gaap	Assets Assets	1503559000	USD
CY2019Q4	us-gaap	Assets Assets	1518861000	USD
CY2020Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	296669000	USD
CY2019Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	295911000	USD
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	198925000	USD
CY2019Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	198713000	USD
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	50000000	USD
CY2019Q4	us-gaap	Line Of Credit LineOfCredit	60000000	USD
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	19572000	USD
CY2019Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	14962000	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	24251000	USD
CY2019Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	21684000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	589417000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	591270000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95215797	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	95215797	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	95103270	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95103270	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	952000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	951000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1164402000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1162990000	USD
CY2020Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	251212000	USD
CY2019Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	236350000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	914142000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	927591000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1503559000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1518861000	USD
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	173612000	USD
CY2019	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	155667000	USD
CY2018	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	140073000	USD
CY2018	ctre	Tenant Reimbursement Revenue TenantReimbursementRevenue	11924000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2077000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3389000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3379000	USD
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome	2643000	USD
CY2019	us-gaap	Interest And Other Income InterestAndOtherIncome	4345000	USD
CY2018	us-gaap	Interest And Other Income InterestAndOtherIncome	1565000	USD
CY2020	us-gaap	Revenues Revenues	178332000	USD
CY2019	us-gaap	Revenues Revenues	163401000	USD
CY2018	us-gaap	Revenues Revenues	156941000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52760000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51822000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	45766000	USD
CY2020	us-gaap	Interest Expense InterestExpense	23661000	USD
CY2019	us-gaap	Interest Expense InterestExpense	28125000	USD
CY2018	us-gaap	Interest Expense InterestExpense	27860000	USD
CY2020	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	2836000	USD
CY2019	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3048000	USD
CY2018	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	11924000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1869000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2898000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2964000	USD
CY2020	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	0	USD
CY2019	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	16692000	USD
CY2018	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	0	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2019	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1076000	USD
CY2018	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16302000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15158000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12555000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	97428000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	118819000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	101069000	USD
CY2020	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-37000	USD
CY2019	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1777000	USD
CY2018	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2051000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	80867000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	46359000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	57923000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95200000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93088000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79386000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95207000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93098000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79392000	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	594617000	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	179886000	USD
CY2018	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1289000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3848000	USD
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.82
CY2018	us-gaap	Dividends Common Stock DividendsCommonStock	66738000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	57923000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	768247000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	195924000	USD
CY2019	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-2524000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4104000	USD
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2019	us-gaap	Dividends Common Stock DividendsCommonStock	84519000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	46359000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	927591000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-404000	USD
CY2020	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1995000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3812000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.00
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	95729000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	80867000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	914142000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	80867000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	46359000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	57923000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	52819000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	51866000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45783000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1950000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2003000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1938000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3790000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4104000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3848000	USD
CY2020	us-gaap	Straight Line Rent StraightLineRent	77000	USD
CY2019	us-gaap	Straight Line Rent StraightLineRent	1385000	USD
CY2018	us-gaap	Straight Line Rent StraightLineRent	2333000	USD
CY2020	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	0	USD
CY2019	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	11774000	USD
CY2018	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	0	USD
CY2020	us-gaap	Other Noncash Income OtherNoncashIncome	0	USD
CY2019	us-gaap	Other Noncash Income OtherNoncashIncome	797000	USD
CY2018	us-gaap	Other Noncash Income OtherNoncashIncome	238000	USD
CY2020	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-37000	USD
CY2019	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1777000	USD
CY2018	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2051000	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1346000	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	463000	USD
CY2018	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2020	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	0	USD
CY2019	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	16692000	USD
CY2018	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	0	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2019	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1076000	USD
CY2018	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-825000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6283000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3800000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-387000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	495000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	270000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3791000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2695000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1443000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	145735000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	126295000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	99357000	USD
CY2020	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	89650000	USD
CY2019	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	321458000	USD
CY2018	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	111640000	USD
CY2020	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	8297000	USD
CY2019	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	6289000	USD
CY2018	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	9012000	USD
CY2020	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	30498000	USD
CY2019	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	18246000	USD
CY2018	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	5648000	USD
CY2020	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	80928000	USD
CY2019	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	24283000	USD
CY2018	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	3227000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2327000	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2204000	USD
CY2018	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	USD
CY2020	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	3000000	USD
CY2019	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	0	USD
CY2018	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	5000000	USD
CY2020	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	6608000	USD
CY2019	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	3499000	USD
CY2018	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	13004000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41582000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316007000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-115069000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	404000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	195924000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	179882000	USD
CY2020	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	200000000	USD
CY2018	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	65000000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	243000000	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	65000000	USD
CY2020	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	USD
CY2019	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	100000000	USD
CY2018	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	75000000	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	278000000	USD
CY2018	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	135000000	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4534000	USD
CY2018	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1996000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2524000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1288000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	93161000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	80619000	USD
CY2018	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	62999000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-105561000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	173247000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	45595000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1408000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16465000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29883000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20327000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36792000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6909000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18919000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20327000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36792000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	21691000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	26005000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	25941000	USD
CY2020	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	2568000	USD
CY2019	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	3900000	USD
CY2018	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	3739000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	599000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1010000	USD
CY2018	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2020	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	168000	USD
CY2019	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	242000	USD
CY2018	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	0	USD
CY2020	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	32400000	USD
CY2019	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	27500000	USD
CY2018	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	USD
CY2020Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	28	state
CY2018	ctre	Tenant Reimbursement Revenue TenantReimbursementRevenue	11900000	USD
CY2020	ctre	Real Estate Taxes Paid Offset To Rental Income Gross RealEstateTaxesPaidOffsetToRentalIncomeGross	3100000	USD
CY2019	ctre	Real Estate Taxes Paid Offset To Rental Income Gross RealEstateTaxesPaidOffsetToRentalIncomeGross	2900000	USD
CY2020	ctre	Operating Lease Lease Income Adjustments For Recovery OperatingLeaseLeaseIncomeAdjustmentsForRecovery	1000000.0	USD
CY2020	ctre	Operating Lease Lease Income Adjustments For Collectibility OperatingLeaseLeaseIncomeAdjustmentsForCollectibility	0	USD
CY2019	ctre	Operating Lease Lease Income Adjustments For Collectibility OperatingLeaseLeaseIncomeAdjustmentsForCollectibility	11800000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions.</span>
CY2020Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	9000000.0	USD
CY2019Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	7100000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3800000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4100000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3800000	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company is subject to concentrations of credit risk consisting primarily of operating leases on its owned properties. See Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a discussion of major operator concentration.</span>
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2020Q4	us-gaap	Land Land	205356000	USD
CY2019Q4	us-gaap	Land Land	204154000	USD
CY2020Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1477849000	USD
CY2019Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1400927000	USD
CY2020Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	97836000	USD
CY2019Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	93005000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2352000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1650000	USD
CY2020Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1783393000	USD
CY2019Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1699736000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	335294000	USD
CY2019Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	285536000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1448099000	USD
CY2019Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1414200000	USD
CY2020Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	218	facility
CY2020Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	218	facility
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	174400000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	174497000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	174193000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	174294000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	174396000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	1026675000	USD
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	173612000	USD
CY2019	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	155667000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1898455000	USD
CY2020	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	171309000	USD
CY2019	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	166056000	USD
CY2020	us-gaap	Straight Line Rent StraightLineRent	77000	USD
CY2019	us-gaap	Straight Line Rent StraightLineRent	1385000	USD
CY2020	ctre	Operating Lease Lease Income Adjustments For Collectibility OperatingLeaseLeaseIncomeAdjustmentsForCollectibility	0	USD
CY2019	ctre	Operating Lease Lease Income Adjustments For Collectibility OperatingLeaseLeaseIncomeAdjustmentsForCollectibility	11774000	USD
CY2020	ctre	Operating Lease Lease Income Adjustments For Recovery OperatingLeaseLeaseIncomeAdjustmentsForRecovery	1047000	USD
CY2019	ctre	Operating Lease Lease Income Adjustments For Recovery OperatingLeaseLeaseIncomeAdjustmentsForRecovery	0	USD
CY2020	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	1179000	USD
CY2019	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2019	ctre	Number Of Operators Collection Of Lease Payment Through Maturity Not Probable NumberOfOperatorsCollectionOfLeasePaymentThroughMaturityNotProbable	5	operator
CY2020	ctre	Operating Lease Lease Income Adjustments For Recovery OperatingLeaseLeaseIncomeAdjustmentsForRecovery	1000000.0	USD
CY2020	ctre	Number Of Operators Collection Of Lease Payment Recovered After Write Off NumberOfOperatorsCollectionOfLeasePaymentRecoveredAfterWriteOff	1	operator
CY2020	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	1200000	USD
CY2020	ctre	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	89817000	USD
CY2020	ctre	Operating Leases Anticipated Initial Annual Lease Revenues OperatingLeasesAnticipatedInitialAnnualLeaseRevenues	7598000	USD
CY2020	ctre	Number Of Properties Acquired NumberOfPropertiesAcquired	8	property
CY2020	ctre	Number Of Beds Or Units In Properties Acquired NumberOfBedsOrUnitsInPropertiesAcquired	961	unit
CY2019	ctre	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	326700000	USD
CY2019	ctre	Operating Leases Anticipated Initial Annual Lease Revenues OperatingLeasesAnticipatedInitialAnnualLeaseRevenues	29143000	USD
CY2019	ctre	Number Of Properties Acquired NumberOfPropertiesAcquired	22	property
CY2019	ctre	Number Of Beds Or Units In Properties Acquired NumberOfBedsOrUnitsInPropertiesAcquired	2957	unit
CY2018	ctre	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	113334000	USD
CY2018	ctre	Operating Leases Anticipated Initial Annual Lease Revenues OperatingLeasesAnticipatedInitialAnnualLeaseRevenues	9955000	USD
CY2018	ctre	Number Of Properties Acquired NumberOfPropertiesAcquired	12	property
CY2018	ctre	Number Of Beds Or Units In Properties Acquired NumberOfBedsOrUnitsInPropertiesAcquired	1103	unit
CY2020Q4	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P14Y
CY2020Q4	ctre	Lessor Operating Lease Number Of Renewal Options LessorOperatingLeaseNumberOfRenewalOptions	2	extension_option
CY2020Q4	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P5Y
CY2019Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	34600000	USD
CY2020Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	7200000	USD
CY2020	us-gaap	Interest Income Other InterestIncomeOther	100000	USD
CY2019	us-gaap	Interest Income Other InterestIncomeOther	1300000	USD
CY2020	ctre	Unrecognized Preferred Return From Prior Period Recognized In Current Period UnrecognizedPreferredReturnFromPriorPeriodRecognizedInCurrentPeriod	600000	USD
CY2018	us-gaap	Interest Income Other InterestIncomeOther	200000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2019	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	16700000	USD
CY2020Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	0	USD
CY2019Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2327000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	550000000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	4406000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	545594000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	560000000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	5376000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	554624000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	50000000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	300000000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	200000000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	550000000	USD
CY2020Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000.0	USD
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2020Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2020Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2020-04-15
CY2020Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2020-07-15
CY2020Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2020-10-15
CY2020Q4	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2021-01-15
CY2020Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	23931000	USD
CY2020Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	23931000	USD
CY2020Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	23934000	USD
CY2020Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	23933000	USD
CY2020Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2020-03-31
CY2020Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2020-06-30
CY2020Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2020-09-30
CY2020Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2020-12-31
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.225
CY2019Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.225
CY2019Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.225
CY2019Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.225
CY2019Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2019-04-15
CY2019Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2019-07-15
CY2019Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2019-10-15
CY2019Q4	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2020-01-15
CY2019Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	20011000	USD
CY2019Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	21508000	USD
CY2019Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	21500000	USD
CY2019Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	21500000	USD
CY2019Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2019-03-29
CY2019Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2019-06-28
CY2019Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2019-09-30
CY2019Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2019-12-31
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.205
CY2018Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.205
CY2018Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.205
CY2018Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.205
CY2018Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2018-04-13
CY2018Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2018-07-13
CY2018Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2018-10-15
CY2018Q4	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2019-01-15
CY2018Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	15608000	USD
CY2018Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	16224000	USD
CY2018Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	17196000	USD
CY2018Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	17710000	USD
CY2018Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2018-03-30
CY2018Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2018-06-29
CY2018Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2018-09-28
CY2018Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2018-12-31
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3790000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4104000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3848000	USD
CY2014Q2	ctre	Number Of Separate And Independent Companies After Spin Off NumberOfSeparateAndIndependentCompaniesAfterSpinOff	2	company
CY2020	us-gaap	Net Income Loss NetIncomeLoss	80867000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	46359000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	57923000	USD
CY2020	ctre	Undistributed Earnings Loss Allocated To Participating Securities Basic And Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicAndDiluted	298000	USD
CY2019	ctre	Undistributed Earnings Loss Allocated To Participating Securities Basic And Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicAndDiluted	296000	USD
CY2018	ctre	Undistributed Earnings Loss Allocated To Participating Securities Basic And Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasicAndDiluted	364000	USD
CY2020	ctre	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	80569000	USD
CY2019	ctre	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	46063000	USD
CY2018	ctre	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	57559000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95200000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93088000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79386000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	7000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	10000	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95207000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93098000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79392000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2020Q1	us-gaap	Revenues Revenues	44340000	USD
CY2020Q2	us-gaap	Revenues Revenues	44168000	USD
CY2020Q3	us-gaap	Revenues Revenues	45687000	USD
CY2020Q4	us-gaap	Revenues Revenues	44137000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	19325000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	18935000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	21552000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	21055000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95161000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95208000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95214000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95215000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95161000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95208000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95214000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95244000	shares
CY2019Q1	us-gaap	Revenues Revenues	39658000	USD
CY2019Q2	us-gaap	Revenues Revenues	46201000	USD
CY2019Q3	us-gaap	Revenues Revenues	33314000	USD
CY2019Q4	us-gaap	Revenues Revenues	44228000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	16053000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	19698000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-10054000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	20662000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88010000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94036000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95103000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95103000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88010000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94036000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95103000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95144000	shares
CY2020Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	0	USD
CY2020Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	206497000	USD
CY2020Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	1364511000	USD
CY2020Q4	us-gaap	Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Carrying Costs RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCosts	112197000	USD
CY2020Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	205356000	USD
CY2020Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	1477849000	USD
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1683205000	USD
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	259803000	USD
CY2020Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	1700000000	USD
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1605081000	USD
CY2018Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1368157000	USD
CY2017Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1266484000	USD
CY2020	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	84630000	USD
CY2019	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	318070000	USD
CY2018	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	106208000	USD
CY2020	us-gaap	Real Estate Improvements RealEstateImprovements	7223000	USD
CY2019	us-gaap	Real Estate Improvements RealEstateImprovements	3103000	USD
CY2018	us-gaap	Real Estate Improvements RealEstateImprovements	7230000	USD
CY2020	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2019	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	21465000	USD
CY2018	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2020	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	13729000	USD
CY2019	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	62784000	USD
CY2018	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	11765000	USD
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1683205000	USD
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1605081000	USD
CY2018Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1368157000	USD
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	220359000	USD
CY2018Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	185926000	USD
CY2017Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	152185000	USD
CY2020	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	41914000	USD
CY2019	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	40373000	USD
CY2018	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	34676000	USD
CY2020	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2019	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	5220000	USD
CY2018	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2020	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	2470000	USD
CY2019	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	720000	USD
CY2018	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	935000	USD
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	259803000	USD
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	220359000	USD
CY2018Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	185926000	USD
CY2020Q4	srt	Mortgage Loans On Real Estate Prior Liens1 MortgageLoansOnRealEstatePriorLiens1	110000000	USD
CY2020Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	15000000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	15000000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	15000000.0	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	29500000	USD
CY2018Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	12375000	USD
CY2017Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	12517000	USD
CY2020	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	61258000	USD
CY2019	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	40889000	USD
CY2018	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	0	USD
CY2020	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	75758000	USD
CY2019	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	23764000	USD
CY2018	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	142000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	15000000	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	29500000	USD
CY2018Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	12375000	USD

Files In Submission

Name	View Source	Status
0001628280-21-001797-index-headers.html	Edgar Link	pending
0001628280-21-001797-index.html	Edgar Link	pending
0001628280-21-001797.txt	Edgar Link	pending
0001628280-21-001797-xbrl.zip	Edgar Link	pending
ctre-20201231.htm	Edgar Link	pending
ctre-20201231.xsd	Edgar Link	pending
ctre-20201231_cal.xml	Edgar Link	unprocessable
ctre-20201231_def.xml	Edgar Link	unprocessable
ctre-20201231_g1.jpg	Edgar Link	pending
ctre-20201231_htm.xml	Edgar Link	completed
ctre-20201231_lab.xml	Edgar Link	unprocessable
ctre-20201231_pre.xml	Edgar Link	unprocessable
ctre20201231ex211q4.htm	Edgar Link	pending
ctre20201231ex231q4.htm	Edgar Link	pending
ctre20201231ex232q4.htm	Edgar Link	pending
ctre20201231ex311q4.htm	Edgar Link	pending
ctre20201231ex312q4.htm	Edgar Link	pending
ctre20201231ex32q4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTRE
CareTrust REIT Inc Stock $ctre

2020 Q4 Form 10-K Financial Statement

#000162828021001797 Filed on February 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE CareTrust REIT Inc Stock $ctre

2020 Q4 Form 10-K Financial Statement

#000162828021001797 Filed on February 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE
CareTrust REIT Inc Stock $ctre